Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Pedestrian crossing behavior at midblock crosswalks.

Tezcan HO, Elmorssy M, Aksoy G.

J Safety Res. 2019 Dec;71:49-57. doi: 10.1016/j.jsr.2019.09.014. Epub 2019 Nov 13.

PMID:
31862044
2.

Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients.

Cecener G, Sabour Takanlou L, Sabour Takanlou M, Egeli U, Eskiler GG, Aksoy S, Unal U, Tezcan H, Eryilmaz IE, Gokgoz MS, Tunca B, Cubukcu E, Evrensel T, Cetintas S, Tasdelen I.

Cancer Genet. 2020 Jan;240:23-32. doi: 10.1016/j.cancergen.2019.10.004. Epub 2019 Oct 16.

PMID:
31706072
3.

Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction.

Tunçez A, Altunkeser BB, Öztürk B, Ateş MS, Tezcan H, Aydoğan C, Kırık EC, Yalçın U, Aygül N, Demir K, Akyürek F.

Anatol J Cardiol. 2019 Nov;22(5):240-249. doi: 10.14744/AnatolJCardiol.2019.64249.

4.

Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome.

Altunkeser BB, Tuncez A, Ozturk B, Tezcan H, Ates MS, Yilmaz C, Yalcin MU, Aygul N, Demir K.

Coron Artery Dis. 2019 Jun;30(4):285-290. doi: 10.1097/MCA.0000000000000715.

PMID:
30741744
6.

Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients.

Brenner B, Geva R, Rothney M, Beny A, Dror Y, Steiner M, Hubert A, Idelevich E, Gluzman A, Purim O, Shacham-Shmueli E, Shulman K, Mishaeli M, Man S, Soussan-Gutman L, Tezcan H, Chao C, Shani A, Liebermann N.

Value Health. 2016 Jan;19(1):82-7. doi: 10.1016/j.jval.2015.08.013. Epub 2015 Oct 30.

7.

Employing TDMA Protocol in Neural Nanonetworks in Case of Neuron Specific Faults.

Tezcan H, Oktug SF, Kök FN.

IEEE Trans Nanobioscience. 2015 Sep;14(6):572-80. doi: 10.1109/TNB.2015.2451086. Epub 2015 Jul 1.

PMID:
26151941
8.

Synthesis, spectral analysis, structural elucidation and quantum chemical studies of (E)-methyl-4-[(2-phenylhydrazono)methyl]benzoate.

Şahin ZS, Şenöz H, Tezcan H, Büyükgüngör O.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 May 15;143:91-100. doi: 10.1016/j.saa.2015.02.032. Epub 2015 Feb 16.

PMID:
25721779
9.

Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.

Reimers MS, Kuppen PJ, Lee M, Lopatin M, Tezcan H, Putter H, Clark-Langone K, Liefers GJ, Shak S, van de Velde CJ.

J Natl Cancer Inst. 2014 Sep 26;106(11). pii: dju269. doi: 10.1093/jnci/dju269. Print 2014 Nov.

PMID:
25261968
10.

Comparative experimental and theoretical studies of N-(4-Methylbenzylidene)-N'-(2-carboxyphenyl) hydrazine novel Schiff base.

Tunç T, Tezcan H, Sağlam S, Dilek N.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jun 5;127:490-7. doi: 10.1016/j.saa.2014.02.104. Epub 2014 Mar 4.

PMID:
24657931
11.

The effect of harpin on shelf life of peppers inoculated with Botrytis cinerea.

Tezcan H, Akbudak N, Akbudak B.

J Food Sci Technol. 2013 Dec;50(6):1079-87. doi: 10.1007/s13197-011-0432-y. Epub 2011 Jun 25.

12.

Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.

Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A.

Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26.

14.

Synthesis, spectroscopy, and quantum-chemical calculations on 1-substituted phenyl-3,5-diphenylformazans.

Tezcan H, Tokay N.

Spectrochim Acta A Mol Biomol Spectrosc. 2010 Jan;75(1):54-60. doi: 10.1016/j.saa.2009.09.034. Epub 2009 Oct 4.

PMID:
19910246
15.

Bortezomib: a new therapeutic option for POEMS syndrome.

Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M.

Eur J Haematol. 2010 Feb 1;84(2):175-7. doi: 10.1111/j.1600-0609.2009.01341.x. Epub 2009 Sep 3.

PMID:
19732138
16.

Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes.

Deyneli O, Yazici D, Toprak A, Yuksel M, Aydin H, Tezcan H, Yavuz DG, Akalin S.

Hypertens Res. 2008 Nov;31(11):2065-73. doi: 10.1291/hypres.31.2065.

PMID:
19098379
17.

Evaluation of messenger plant activator as a preharvest and postharvest treatment of sweet cherry fruit under a controlled atmosphere.

Akbudak B, Tezcan H, Eris A.

Int J Food Sci Nutr. 2009 Aug;60(5):374-86. doi: 10.1080/09637480701712420.

PMID:
18671163
18.

DNA methylation in lung cancer.

Tezcan H.

N Engl J Med. 2008 Jun 5;358(23):2514; author reply 2514. No abstract available.

PMID:
18536094
19.

Synthesis, spectroscopic and electrochemical studies on bis-[1,3-substituted (Cl, Br) phenyl-5-phenyl formazanato]nickel(II) complexes.

Tezcan H, Uzluk E, Aksu ML.

Spectrochim Acta A Mol Biomol Spectrosc. 2008 Oct;70(5):973-82. Epub 2007 Oct 13.

PMID:
18055250
20.

Temporal effects of low-dose ACE inhibition on endothelial function in Type 1 diabetic patients.

Yazici D, Yavuz DG, Unsalan S, Toprak A, Yüksel M, Deyneli O, Aydin H, Tezcan H, Rollas S, Akalin S.

J Endocrinol Invest. 2007 Oct;30(9):726-33.

PMID:
17993763
21.

Synthesis and spectral properties of some bis-substituted formazans.

Tezcan H.

Spectrochim Acta A Mol Biomol Spectrosc. 2008 Mar;69(3):971-9. Epub 2007 Jun 5.

PMID:
17627872
22.

Interaction between C-reactive protein and endothelin-1 in coronary artery disease.

Gemici G, Erdim R, Tokay S, Tezcan H, Fak AS, Oktay A.

Cardiology. 2007;107(4):340-4. Epub 2007 Feb 1.

PMID:
17283423
23.

Electrochemical investigation of 1,3,5-triphenylformazan and its nitro derivatives in dimethyl sulfoxide.

Gökce G, Durmuş Z, Tezcan H, Kiliç E, Yilmaz H.

Anal Sci. 2005 Jun;21(6):685-8.

24.

Prevalence and factors affecting headache in Turkish schoolchildren.

Bugdayci R, Ozge A, Sasmaz T, Kurt AO, Kaleagasi H, Karakelle A, Tezcan H, Siva A.

Pediatr Int. 2005 Jun;47(3):316-22.

PMID:
15910458
25.

Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia.

Gemici G, Tezcan H, Fak AS, Oktay A.

Pacing Clin Electrophysiol. 2004 Apr;27(4):557-8.

PMID:
15078417
26.

A cross-sectional prevalence study of depression at various times after delivery in Mersin province in Turkey.

Bugdayci R, Sasmaz CT, Tezcan H, Kurt AO, Oner S.

J Womens Health (Larchmt). 2004 Jan-Feb;13(1):63-8.

PMID:
15006278
27.

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.

Hesketh PJ, Arena F, Patel D, Austin M, D'Avirro P, Rossi G, Colowick A, Schwartzberg L, Bertoli LF, Cole JT, Demetri G, Dessypris E, Dobbs T, Eisenberg P, Fleischman R, Hall J, Hoffman PC, Laber DA, Leonard J, Lester EP, McCachren S, McMeekin S, Meza L, Miller DS, Nand S, Oliff I, Paroly W, Pawl L, Perez A, Raftopoulos H, Rigas J, Rowland K, Scullin DC Jr, Tezcan H, Waples J, Ward J, Yee LK.

Cancer. 2004 Feb 15;100(4):859-68.

28.

Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study.

Toprak A, Koc M, Tezcan H, Ozener IC, Akoglu E, Oktay A.

Nephrol Dial Transplant. 2003 Oct;18(10):2128-33.

PMID:
13679491
29.

N-(4-nitrobenzylidene)-N'-phenylhydrazine.

Tunç T, Tezcan H, Sari M, Büyükgüngör O, Yagbasan R.

Acta Crystallogr C. 2003 Sep;59(Pt 9):o528-9. Epub 2003 Aug 16.

PMID:
12944667
30.

Crystal structure of 2,3-diaza-1,3-diphenylpropene.

Güneş B, Ozbey S, Tezcan H.

Anal Sci. 2003 Jul;19(7):1091-2.

31.

Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.

Tezcan H, Yavuz D, Toprak A, Akpinar I, Koç M, Deyneli O, Akalin S.

J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):119-23.

PMID:
12806595
32.

N-(4-Methoxybenzylidene)-N'-(2-pyridyl)hydrazine.

Tunç T, Sari M, Yagbasan R, Tezcan H, Sahin E.

Acta Crystallogr C. 2003 Apr;59(Pt 4):O192-3. Epub 2003 Mar 21.

PMID:
12682405
33.

Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients.

Toprak A, Koc M, Tezcan H, Ozener IC, Oktay A, Akoglu E.

J Hum Hypertens. 2003 Apr;17(4):239-44.

PMID:
12692568
34.

The sensitivity and specificity of the case definition criteria in diagnosis of headache: a school-based epidemiological study of 5562 children in Mersin.

Ozge A, Bŭgdayci R, Saşmaz T, Kaleăgasi H, Kurt O, Karakelle A, Tezcan H, Siva A.

Cephalalgia. 2003 Mar;23(2):138-45.

PMID:
12603371
35.

The sensitivity and specificity of the case definition criteria in diagnosis of headache: a school-based epidemiological study of 5562 children in Mersin.

Ozge A, Bugdayci R, Sasmaz T, Kaleagasi H, Kurt O, Karakelle A, Tezcan H, Siva A.

Cephalalgia. 2002 Dec;22(10):791-8.

PMID:
12485204
36.

Coronary stent implantation in Behçet's disease.

Tezcan H, Yavuz S, Fak AS, Aker U, Direskeneli H.

Clin Exp Rheumatol. 2002 Sep-Oct;20(5):704-6.

PMID:
12412205
37.

Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients.

Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC.

Nephrol Dial Transplant. 2002 Sep;17(9):1661-6.

PMID:
12198220
38.

QT dispersion in renal transplant recipients.

Koc M, Toprak A, Ozener IC, Bihorac A, Tezcan H, Fak AS, Akoglu E.

Nephron. 2002 Jun;91(2):250-4.

PMID:
12053061
39.

Association between salt sensitivity and target organ damage in essential hypertension.

Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E.

Am J Hypertens. 2000 Aug;13(8):864-72.

PMID:
10950394
40.

Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions.

Caymaz O, Fak AS, Tezcan H, Inanir S S, Toprak A, Tokay S, Turoglu T, Oktay A.

J Invasive Cardiol. 2000 Jul;12(7):345-50.

PMID:
10904440
41.

Measurement of myocardial fractional flow reserve during coronary angioplasty in infarct-related and non-infarct related coronary artery lesions.

Caymaz O, Tezcan H, Fak AS, Toprak A, Tokay S, Oktay A.

J Invasive Cardiol. 2000 May;12(5):236-41.

PMID:
10825764
42.

Left ventricular hypertrophy and angiotensin-converting enzyme gene polymorphism in renal allograft recipients.

Koç M, Ozener IC, Tezcan H, Bihorac A, Isbir T, Akoğlu E.

Transplant Proc. 2000 May;32(3):542-4. No abstract available.

PMID:
10812105
43.

Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study.

Fak AS, Tezcan H, Caymaz O, Tokay S, Oktay S, Oktay A.

J Cardiovasc Pharmacol Ther. 1997 Oct;2(4):251-258.

PMID:
10684466
44.

Urinary glycosaminoglycan excretion in newly diagnosed essential hypertensive patients.

Yavuz D, Toprak A, Budak Y, Ersöz HO, Deyneli O, Tezcan H, Akalin S.

Clin Chem. 2000 Feb;46(2):299-301. No abstract available.

45.
46.
47.

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.

Schriber J, Milk B, Shaw D, Christiansen N, Baer M, Slack J, Tezcan H, Wetzler M, Herzig G.

Bone Marrow Transplant. 1999 Dec;24(12):1311-4.

48.

Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.

Tezcan H, Vose JM, Bast M, Bierman PJ, Kessinger A, Armitage JO.

Leuk Lymphoma. 1999 Jul;34(3-4):273-85. Review.

PMID:
10439364
49.

Additive effects of simvastatin and hormone replacement therapy in hypercholesterolemic postmenopausal women.

Fak AS, Erenus M, Tezcan H, Caymaz O, Atagündüz P, Tokay S, Toprak A, Oktay S, Oktay A.

J Am Coll Cardiol. 1999 Jul;34(1):311-2. No abstract available.

50.

Association between left atrial enlargement and target organ damage in essential hypertension.

Tezcan H, Bihorac A, Akoglu E, Oktay A.

Am J Hypertens. 1998 Jun;11(6 Pt 1):732-3. No abstract available.

PMID:
9657634

Supplemental Content

Loading ...
Support Center